Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

Jin, J., Tarrant, R. D., Bolam, E. J., Angell-Manning, P., Soegaard, M., Pattinson, D. J., Dulal, P., Silk, S. E., Marshall, J. M., Dabbs, R. A., Nugent, F. L., Barrett, J. R., Hjerrild, K. A., Poulsen, L., Jørgensen, T., Brenner, T., Baleanu, I. N., Parracho, H. M., Tahiri-Alaoui, A., Whale, G., Moyle, S., Payne, R. O., Minassian, A. M., Higgins, M. K., Detmers, F. J., Lawrie, A. M., Douglas, A. D., Smith, R., de Jongh, W. A., Berrie, E., Ashfield, R. and Draper, S. J.  Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells.  Npj Vaccines. 2018; 3:32, 1-13.  doi:10.1038/s41541-018-0071-7